JB Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
90,288
+81,140
+887% +$18.9M 0.79% 28
2026
Q1
$2.24M Buy
9,148
+3
+0% +$699 0.09% 106
2025
Q4
$1.89M Buy
9,145
+147
+2% +$29.1K 0.08% 116
2025
Q3
$1.67M Sell
8,998
-13
-0.1% -$2.23K 0.07% 120
2025
Q2
$1.38M Buy
9,011
+360
+4% +$55.3K 0.07% 115
2025
Q1
$1.43M Sell
8,651
-106
-1% -$16.6K 0.08% 107
2024
Q4
$1.27M Sell
8,757
-386
-4% -$59.8K 0.07% 105
2024
Q3
$1.48M Hold
9,143
0.09% 101
2024
Q2
$1.34M Sell
9,143
-22,864
-71% -$3.4M 0.08% 105
2024
Q1
$5.06M Buy
32,007
+663
+2% +$106K 0.34% 41
2023
Q4
$4.91M Buy
31,344
+1,513
+5% +$232K 0.36% 41
2023
Q3
$4.65M Buy
29,831
+857
+3% +$141K 0.39% 42
2023
Q2
$4.8M Buy
28,974
+1,086
+4% +$175K 0.4% 41
2023
Q1
$4.32M Buy
27,888
+2,142
+8% +$346K 0.39% 45
2022
Q4
$4.55M Buy
25,746
+1,600
+7% +$276K 0.45% 48
2022
Q3
$3.94M Buy
24,146
+4,631
+24% +$784K 0.43% 48
2022
Q2
$3.46M Buy
19,515
+964
+5% +$172K 0.37% 35
2022
Q1
$3.29M Buy
18,551
+740
+4% +$126K 0.32% 35
2021
Q4
$3.05M Buy
17,811
+699
+4% +$114K 0.3% 37
2021
Q3
$2.76M Buy
+17,112
New +$2.92M 0.36% 38

Other funds holding JNJ

JB Capital's JNJ Position: Q2 2026 in Review

JB Capital increased its Johnson & Johnson (JNJ) stake by 887% in Q2 2026, buying an estimated $18.9M and bringing the position to 90,288 shares worth $22.9M. The position accounts for 0.79% of the portfolio, ranked #28.

JB Capital first reported a position in JNJ in Q3 2021 and has held it in 20 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • JB Capital held 90,288 shares of Johnson & Johnson worth $22.9M as of Q2 2026.
  • JB Capital bought 81,140 Johnson & Johnson shares in Q2 2026, an estimated $18.9M.
  • Johnson & Johnson made up 0.79% of JB Capital's portfolio in Q2 2026, its #28 holding.
  • JB Capital first reported a position in Johnson & Johnson in Q3 2021 and has held it in 20 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.